Child and Adolescent Health and Development

 

Integrated Management of Child Health

Contact us   |   Links |   CAH home  |  EMRO website

What is IMCI

Adaptations

Implementation

Healthy child

Nutrition

Development

 
  • Rationale

  • Principles

  • Process

  • Adaptations in the Region

  .
 

Rationale


The WHO/UNICEF “generic” IMCI guidelines were originally designed to address the most common causes of mortality in children age 1 week up to five years old especially in countries with an infant mortality higher than 40 per 1000 live births. In these situations, there is often a substantial incidence of communicable diseases in children under-5 taken to primary health care facilities, and risk factors such as malnutrition and low birth weight are common.

 

-- Link --

Generic version of IMCI guidelines
English

-- Download --

Generic version of IMCI guidelines
French (pdf, 361 kb)

 

The generic version of the guidelines therefore concentrates on the outpatient management of the following conditions: 

  • Acute respiratory infections, including pneumonia;

  • Diarrhoeal diseases, including dehydration, bloody and persistent diarrhoea;

  • Meningitis and sepsis;

  • Malaria;

  • Measles

  • Ear infection;

  • Malnutrition; and

  • Anaemia.

The generic guidelines need to be adapted in countries, to take into consideration local epidemiology, existing policies, drug resistance patterns, essential drugs availability, feasibility of implementation through the existing health system, and local terminology used in communities to refer to common illness entities. Recommendations on foods and fluids also need to be adapted. WHO has developed an “Adaptation Guide” to facilitate the adaptation process.   Top

  .
 

Principles

The adaptation of the IMCI guidelines should rely as much as possible on evidence and be guided by a number of public health principles. The generic guidelines are meant to target the leading causes of mortality and (severe) morbidity in children below five years of age, who are a particularly vulnerable age group. The guidelines therefore intentionally cover only priority public health conditions rather than all paediatric conditions. In the same way, country adaptations must follow a number of principles, which are described below. The ultimate product of the adaptation process should be guidelines that are safe and effective when used at primary health care level.

  • Leading causes of mortality and morbidity

  • Sensitive and specific clinical signs

  • Minimum number of clinical signs

  • Requiring simple skills

  • Possible to teach and learn

  • Minimum number of essential drugs

  • Best care possible for severe cases


Leading causes of mortality and morbidity

The inclusion of other conditions than those covered in the generic version must be based on a solid justification, including the expected advantages from a public health perspective. For example, the argumentation in favour of including the management of streptococcal pharyngitis in some countries has been the need for a rationalisation of drug use for children presenting with sore throat, and the expectation that the availability of standard guidelines would help reduce health care costs for both the health system and the users. There are conditions that are not a major cause of mortality but are included because they are a preventable cause of long-term or life-long disabilities (e.g., ear infections, which may result in hearing problems). 

The number of conditions must be limited, so that they can be covered properly in a quality short training course such as IMCI. At the end of the examination of the child, the guidelines remind the health provider to look for any “other problems” not specifically listed in the chart and to manage these problems according to the pre-service training they have received.   Top


Sensitive and specific clinical signs

The guidelines in most cases rely just on clinical signs, as laboratory, X-ray or other diagnostic facilities are most often unavailable at primary health care level in developing countries. The signs and symptoms selected in the algorithm must be sensitive and specific. The concern is to avoid missing cases which have the condition while at the same time avoiding over-treatment and over-referral of cases which do not have the condition. In principle, new clinical decision rules should first be validated before being included in the guidelines, rather than be only derived from expert opinion (see “Research”).   Top


Minimum number of clinical signs

The guidelines must be practical to be used reliably by primary health care providers and must then include a limited number of clinical signs that can be learnt during a short training course. It should be emphasised that the guidelines are action-oriented: rather than leading to specific diagnoses, the guidelines aim at assisting the health provider in identifying (“classifying”) conditions in three main groups: those which require urgent referral, treatment or counselling on home care. Any additional signs which do not improve the performance of the guidelines should not be included.   Top 

Requiring simple skills

The guidelines are meant to be used by a wide range of health providers working at primary health care level. Their skills vary and guidelines requiring simple skills are more likely to be used properly than those relying on more complex skills.    Top
 

Possible to teach and learn

The assessment of signs and treatment approaches should be easy to teach—and to be learnt— within the short duration of an in-service training course.   Top
 

Minimum number of essential drugs

The guidelines should rely on a minimum number of drugs that can be made available and used safely at primary health care level and that are the least expensive.   Top
 

Best care possible for severe cases

However simple the guidelines may appear, they must enable the delivery of the best possible care, especially the detection, pre-referral treatment and urgent referral of the most severe cases.   Top

 
 

Process


The final adaptation of the guidelines must be the result of a large consensus achieved within the professional community in the country.

-- Link --

IMCI adaptation guide

The process therefore requires good coordination and a specific group established for this particular task, the adaptation sub-group, which reports to the main IMCI Working Group or Committee. In some countries, this sub-group consists of several teams of experts, each working on the adaptation of specific issues. Resource persons from the country are consulted throughout the process, whether within or outside the adaptation sub-group. In most countries in the Region, the Child and Adolescent Health and Development unit of the Regional Office has provided direct technical support to the adaptation process.

The duration of the process varies from country to country, from a few months to a year or more. This process is however very important, playing an advocacy role and giving a sense of ownership, and is therefore key to future implementation of the IMCI strategy. This is because it brings together representatives of the Ministry of health, professional societies and academe, including medical schools, international and bilateral organizations, to generate an output by broad consensus. This consensus promotes further collaboration during implementation and reinforces the foundation of the strategy in the country. For example, senior, highly respected paediatricians in countries have joined in-service IMCI training courses as facilitators, participated in follow-up visits after training and eventually played a leading role in the introduction of the IMCI approach in medical schools. 

The adaptation process concerns not only the clinical guidelines, but also the feeding recommendations and the care-seeking process, by identifying local terminology used in communi­ties to refer to illness entities and to be used in health communication initiatives. 

The complete IMCI Adaptation Guide Version 5, with a description of tasks, the technical basis for the generic guidelines, the process and instruments is available at the WHO/HQ CAH website.   Top

 
 

Adaptations in the Region

 

The links below open windows with tables showing a summary of the main adaptations of the generic IMCI clinical guidelines that have been carried out by countries in the Region. The Oman IMCI guidelines used the WHO/UNICEF generic version of the IMCI guidelines as a reference but embarked on major adaptations, which included many new conditions. 

  • Assessment and classification

  • Treatment (1): Antibiotics

  • Treatment (2): Antimalarials and other drugs

  • Prevention: Immunization schedule and vitamin A supplementation

  • List of drugs included in the IMCI guidelines by country

 

 

-- Downloads --

To see the adapted IMCI chart booklets—which contain the IMCI technical guidelines—by country, click on the language under the name of the country.

Afghanistan
 English (pdf, 1.3 MB)
 Dari (730 kb)
 Pashto (770 kb)

Djibouti
 French  (pdf, 889 kb) 2008
 French (pdf, 374 kb)

Egypt
English (pdf, 5.6 MB) Rev. 2010 
English (
pdf, 910 kb) Rev. 2008
 English (pdf, 320 kb)

Islamic Republic of Iran
 Farsi (pdf, 2.2 MB)

Iraq
 English (pdf, 764 kb), Rev. 2006

Morocco
French
(pdf, 1.5 MB), Rev. 2009
French
(pdf, 2.4 MB), Rev. 2006
French (pdf, 346 kb), Rev. 2004

Oman

 English (pdf, 321 kb)

Pakistan
English Rev. 2010 (pdf, 1.4 MB)
English 
(pdf, 3.5 MB)  

Occupied Palestinian territory
English (pdf, 1.3 MB)
 

Sudan
Arabic (word document, 728 kb)
English (pdf, 1MB) Rev. 2008
English (pdf, 592 kb)

Saudi Arabia
 English (pdf, 446 kb)

Syrian Arab Republic
 Arabic (pdf, 1 MB)  

Tunisia
 French (pdf, 259 kb) 

Yemen
 English
(pdf, 7 MB), Rev. 2008
 English (pdf, 406 kb)